CoChat

Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research

Open access
Schnell, Oliver, Barnard, Katharine, Bergenstal, Richard, Bosi, Emanuele, Garg, Satish, Guerci, Bruno, Haak, Thomas, Hirsch, Irl B., Ji, Linong, Joshi, Sashank R., Kamp, Maarten, Laffel, Lori, Mathieu, Chantal, Polonsky, William H., Snoek, Frank, Home, Philip · 2015 · Diabetes Care
Cited by 36

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Quality glucose information is a core prerequisite for successful diabetes management.It enables professionals and people with diabetes to make medically relevant decisions on therapy.Details of glucose profile information beyond HbA 1c have been largely derived from self-monitoring of blood glucose (SMBG).Given the evidence base demonstrating the benefits of SMBG, its routine use is recommended for diabetes management and therapy by many international and regional guidelines (1-3).Today, SMBG is considered an important aspect of the management of glycemic control (3,4).Glucose information of high quality, considering the products used and the processes conducted, is also needed in clinical research in order to gain new evidence and insights on effective treatment strategies in diabetes.SMBG is widely and routinely applied in large clinical trials, where it is used to understand the glycemic state, to enhance awareness of the effects of lifestyle modification and the adaptation of treatment including insulin titration, and to enable documentation of intraday pre-and postprandial glucose excursions (glycemic variability) and the subsequent statistical analysis of this and the confirmation of hypoglycemic episodes.Examples of recent studies that used SMBG are Outcome Reduction With Initial Glargine Intervention (ORIGIN) trial, Action to Control Cardiovascular Risk in Diabetes (ACCORD), and, from earlier times, the Diabetes Control and Complications Trial (DCCT) (5-8).Indeed, SMBG is now applied in most studies of glucoselowering agents, including glucagon-like peptide 1 (GLP-1) receptor agonist and sodium-glucose cotransporter 2 (SGLT2) inhibitor studies.Reliable glucose information requires a clear definition as part of the study design and protocol, not least to ensure replication of the methodology.Interpretation and comparison of study results may be affected if SMBG methods and results are addressed inconsistently.With regard to the interpretation of outcomes of studies, reporting of SMBG in publications should be of the highest qualitydaccurate, precise, reliable, and reproducible.In many publications, however, relevant details of the SMBG measures are lacking or are incomplete.Therefore, the interpretation of study results may be hampered, reliability of study results may be compromised, and repetition of trials may become necessary.This consensus publication not only aims to summarize learnings from previous clinical studies about the use and reporting of SMBG but also proposes recommendations for the description of the performance and reporting of SMBG in future clinical study protocols and related publications.Clinical trials aim at expanding knowledge and evidence.One major principle of Good Clinical Practice is to conduct clinical studies at a quality standard that provides the highest level of safety for the study participants but also avoids a potentially unnecessary burden on participants by inefficient repetition of the experiments with "human beings" to answer a clinical/scientific question.In clinical trials, SMBG is performed by participants to provide information on (fluctuating) blood glucose concentrations and as a means to guide titration (as per protocol).All current tests require pricking a finger with a lancet device to obtain a small blood sample and applying a drop of blood to a test strip or tape, with the glucose concentration analyzed by a glucose meter for an automated reading.Test results are stored in the blood glucose meter's electronic memory for further use (9).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-2919

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 36

Metadata

Authors
Schnell, O., Barnard, K., Bergenstal, R., Bosi, E., Garg, S., Guerci, B., Haak, T., Hirsch, I. B., Ji, L., Joshi, S. R., Kamp, M., Laffel, L., Mathieu, C., Polonsky, W. H., Snoek, F., & Home, P.
Venue
Diabetes Care
Published
2015-08-10
Volume
38
Issue
9
Pages
1627-1633
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2117349244
Cited by
36
References
17
FWCI
2.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.